论文部分内容阅读
低度恶性滤泡型淋巴瘤(LGFL)的治疗面临着挑战,除常规治疗方法外,近年来一些新的治疗方法陆续有过报道,如干扰素、自体骨髓移植或fludarabine治疗等,治疗标准尚不统一。为了给今后LGFL治疗方法的选择提供一定的依据,作者对91例LGFL病人总体生存情况及首次病变进展后的生存情况进行了研究。 91例LGFL病例组织学分类:小裂细胞型75例、混合细胞型16例。63例有≥1个部位的结外病
The treatment of low-grade follicular lymphoma (LGFL) faces challenges. In addition to the conventional treatment methods, some new treatment methods have been reported in recent years, such as interferon, autologous bone marrow transplantation or fludarabine, Not the same. In order to provide a basis for the future selection of LGFL treatment methods, the authors investigated the overall survival of 91 patients with LGFL and the survival after the first lesion. 91 cases of LGFL histological classification: 75 cases of small cell type, mixed cell type in 16 cases. 63 cases had more than 1 sites of extra-nidus disease